Rapport stock rockets nearly 200% today, but analysts warn of possible crash soon

Core Insights - Rapport stock (NASDAQ: RAPP) experienced a significant surge, climbing nearly 200% in a single trading session [1] - The increase in stock price was driven by excitement surrounding upcoming clinical trial data and a growing confidence in the company's prospects [1] Company Summary - The stock's dramatic rise indicates strong market interest and investor sentiment towards Rapport, likely influenced by anticipated positive outcomes from clinical trials [1] - The confidence in the company's future performance suggests potential for further growth and investment opportunities in the biotech sector [1]